DIA466.77+1.71 0.37%
SPY658.93+3.10 0.47%
QQQ588.50+3.52 0.60%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga·03/11/2026 12:06:01
Listen to the news

Gainers

  • Kala Bio (NASDAQ:KALA) shares rose 63.3% to $0.48 during Wednesday's pre-market session. The market value of their outstanding shares is at $267.8 million.
  • SCWorx (NASDAQ:WORX) shares moved upwards by 20.37% to $0.15. The market value of their outstanding shares is at $2.0 million.
  • Auna (NYSE:AUNA) stock rose 18.77% to $5.7. The market value of their outstanding shares is at $355.2 million. As per the news, the Q4 earnings report came out yesterday.
  • SS Innovations (NASDAQ:SSII) stock moved upwards by 17.19% to $5.18. The market value of their outstanding shares is at $859.0 million. As per the news, the Q4 earnings report came out yesterday.
  • Acurx Pharmaceuticals (NASDAQ:ACXP) stock increased by 14.13% to $3.31. The market value of their outstanding shares is at $7.3 million.
  • Damora Therapeutics (NASDAQ:DMRA) stock increased by 14.07% to $29.1. The market value of their outstanding shares is at $1.5 billion.

Losers

  • Skye Bioscience (NASDAQ:SKYE) shares decreased by 18.6% to $0.65 during Wednesday's pre-market session. The market value of their outstanding shares is at $25.6 million. As per the press release, Q4 earnings came out yesterday.
  • MiNK Therapeutics (NASDAQ:INKT) shares decreased by 15.77% to $11.38. The market value of their outstanding shares is at $63.4 million.
  • Pomdoctor (NASDAQ:POM) shares declined by 13.16% to $0.28. The market value of their outstanding shares is at $38.1 million.
  • Cuprina Holdings (Cayman) (NASDAQ:CUPR) shares fell 12.95% to $0.32. The market value of their outstanding shares is at $2.7 million.
  • Verrica Pharmaceuticals (NASDAQ:VRCA) shares fell 12.21% to $5.25. The market value of their outstanding shares is at $95.6 million. The company's, Q4 earnings came out today.
  • Longeveron (NASDAQ:LGVN) stock declined by 11.34% to $0.79. The company's market cap stands at $19.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.